-
Ready, set, snooze: Sleep-deprived Japanese compete for best-rested
-
Changer+ Launches Stablecoin-First Self-Custodial Wallet to Make Stablecoins Easier to Use
-
Falcons thump Saints 45-24 as New Orleans marks Katrina anniversary
-
White Sox down Guardians, Yankees on brink after Rays loss
-
Tuvalu govt adviser says Australia overstepped in pre-COP visit
-
COP31 eyes modest steps as climate disasters multiply
-
Asian stocks mixed despite tech-led Wall St record
-
American Nobel laureate in medicine hopes to illuminate the brain
-
Tens of thousands expected in Paris for high school protests
-
Trump approves firing squad for convicted US military base shooter
-
AI borrowing binge rattles US markets
-
Grappling with 'homework scams,' US universities shun AI detectors
-
Young Canadians sue government over alleged climate failures
-
Separatists win Quebec election in test for Canada PM
-
White Sox down Guardians to take 2-0 series lead
-
Gold IRA Rules, Taxes, Eligible Metals, RMD and Depositories Explained in New Guide by IRAEmpire
-
Leaders visit Pacific atoll at frontline of climate change
-
NHL record-breaker Ovechkin says current season will be his last
-
Yemen's Houthis claim striking Riyadh airport, other Saudi sites
-
France roar back in Nations League as Italy beat Turkey
-
Best-selling British author Jeffrey Archer dies aged 86
-
Messi readies for final farewell in Argentina send-off
-
Military plane crash kills 32 in Nigeria
-
Esposito seals Italy win over Turkey in Nations League
-
Olise powers France to win over Belgium in Nations League
-
Russia downplays plague reports as Trump offers US help
-
High-flying Blazy turns to birdlife at Chanel
-
Trump says US moved bombers from UK base after 'threats'
-
Riyadh's allies pledge troops as Yemen, Saudi Arabia attack Houthis
-
Brazilian stocks surge to record after Bolsonaro election lead
-
Clashes erupt outside Kosovo parliament over war crimes court
-
Leaders to visit Pacific atoll at frontline of climate change
-
Milan's Saelemaekers suffers ankle setback, faces lengthy spell out
-
ICC gives more details about arrest warrants for Taliban ministers
-
Rubio arrives in Iceland to push for greater US presence in Arctic
-
Nigeria's Tinubu confirms 32 dead after military plane crash
-
Putin allows Italy's UniCredit to sell part of Russian business
-
'Reckless' AI firms can't control models, says whistleblower
-
Djokovic into China Open final as Medvedev out for hitting fan with ball
-
Switching on brain cells: the Nobel-winning science of optogenetics
-
ICC unseals arrest warrants for Taliban education ministers
-
Quebec votes as separatist surge poses test for Canada PM
-
Modric hopes fans back Croatia against Spain after England shame
-
Euro slides as concerns about French debt mount
-
Bolsonaro rides right-wing surge into Brazil's election runoff
-
Former Trump press secretary Leavitt joins Fox News
-
Turkey blocks X account of British reporter
-
Djokovic advances to China Open final as Medvedev out for hitting fan with ball
-
Ukraine says using AI robot guns to shoot down new Russian drones
-
Disgraced former US House speaker dies at 84
The Functional Mushroom Revolution Has Begun
Hypha Labs (OTCQB:FUNI) Is Building the Technology to Scale the Industry
LAS VEGAS, NV / ACCESS Newswire / July 27, 2026 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company developing automated mushroom production technologies, believes the functional mushroom industry is entering its next phase of growth-one where scalable manufacturing may become as important as consumer demand.
As the global market for functional mushrooms continues to expand across wellness, nutrition, beverages, and dietary supplements, Hypha Labs is focused on developing production technology designed to improve efficiency, consistency, and commercial scalability.
"We believe the next leaders in this industry will be the companies that enable large-scale production," said Stone Douglass, Chief Executive Officer of Hypha Labs. "Our goal is to help transform mushroom cultivation into a more automated, consistent, and scalable manufacturing process."
Hypha Labs' proprietary Mushroom Accelerator™ platform is being developed to reduce production time, improve consistency, and support commercial-scale manufacturing of mushroom-derived ingredients.
"Every emerging industry eventually reaches a point where manufacturing innovation becomes the competitive advantage," Douglass added. "We believe functional mushrooms are approaching that moment, and Hypha Labs intends to help lead that transformation."
As consumer demand and scientific interest continue to accelerate, Hypha Labs believes advanced production technology will play a critical role in supporting the industry's long-term growth.
About Hypha Labs, Inc.
Hypha Labs, Inc. (OTCQB:FUNI) is developing proprietary automated mushroom production technologies designed to improve scalability, consistency, and manufacturing efficiency for the rapidly growing functional mushroom industry.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to risks and uncertainties described in the Company's filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements except as required by law.
From time to time, the Company may post new material information on its website or through its social media profiles at the links below:
LN: https://www.linkedin.com/company/hypha-labs-inc/
FB: https://www.facebook.com/hyphalabs
IG: https://www.instagram.com/hyphalabsinc/
Twitter: https://x.com/Hypha_Labs
For more information about Hypha Labs visit
HyphaLabs.com
For the Company's current Investor Presentation please visit
www.HyphaLabs.com/deck
Contact
Hypha Labs, Inc.
702 744 0640
[email protected]
SOURCE: Hypha Labs, Inc.
View the original press release on ACCESS Newswire
M.A.Colin--AMWN